Product Name

  • Name

    3-FORMYL RIFAMYCIN SV

  • EINECS 236-311-5
  • CAS No. 13292-22-3
  • Article Data6
  • CAS DataBase
  • Density 1.37 g/cm3
  • Solubility
  • Melting Point 182-184°C
  • Formula C38H47NO13
  • Boiling Point 855.4 °C at 760 mmHg
  • Molecular Weight 725.79
  • Flash Point 471.1 °C
  • Transport Information
  • Appearance Black-Red Solid
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 13292-22-3 (3-FORMYL RIFAMYCIN SV)
  • Hazard Symbols
  • Synonyms 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-8-carboxaldehyde,1,2-dihydro-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-,21-acetate (7CI,8CI);3-Formylrifampicin SV;3-Formylrifamycin;3-Formylrifamycin SV;NCI 145-635;Rifaldehyde;Rifamycin AF;
  • PSA 218.38000
  • LogP 4.70460

Synthetic route

rifampicin
13292-46-1

rifampicin

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

Conditions
ConditionsYield
With hydrogenchloride; water at 55℃; for 8h; Temperature;95%
With hydrogenchloride; water In diethyl ether at 20℃; for 96h;89%
With ascorbic acid In hydrogenchloride at 50℃; for 12h;
With isoniazid for 24h;
rifampicin
13292-46-1

rifampicin

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

Conditions
ConditionsYield
With hydrogenchloride In diethyl ether; water at 20℃; for 96h;88.9%
C38H48NO16S(1-)*Na(1+)

C38H48NO16S(1-)*Na(1+)

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

Conditions
ConditionsYield
With sodium hydrogencarbonate In water pH=7;78.17 g
C38H48NO16S(1-)*K(1+)

C38H48NO16S(1-)*K(1+)

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

Conditions
ConditionsYield
With potassium hydrogencarbonate In water pH=7;76.34g
N1-cinnamyl-N4-amino piperazine
41379-00-4

N1-cinnamyl-N4-amino piperazine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV

3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV

Conditions
ConditionsYield
With acetic acid In ethanol at 20 - 30℃; for 2h;98%
pyrrolidine
123-75-1

pyrrolidine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

4-methyl-2-pentanone
108-10-1

4-methyl-2-pentanone

3-[5-methyl-3-(pyrrolidine-1-ylidenium)hex-1-ene-1-yl]rifamycin SV-8-olate

3-[5-methyl-3-(pyrrolidine-1-ylidenium)hex-1-ene-1-yl]rifamycin SV-8-olate

Conditions
ConditionsYield
With acetic acid In methanol at 40 - 52℃; for 0.5h;97.9%
3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

1-amino-4-(2-hydroxyethyl)-piperazine
3973-70-4

1-amino-4-(2-hydroxyethyl)-piperazine

3-(((4-(2-hydroxyethyl)-1-piperazinyl)imino)methyl)rifamycin

3-(((4-(2-hydroxyethyl)-1-piperazinyl)imino)methyl)rifamycin

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 0.25h;97%
3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

1-amino-4-propargylpiperazine
56964-23-9

1-amino-4-propargylpiperazine

C45H58N4O12
56964-37-5

C45H58N4O12

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 0.333333h;97%
In tetrahydrofuran for 0.25h;94%
In tetrahydrofuran at 20℃; for 0.25h; Schlenk technique; Inert atmosphere;91%
pyrrolidine
123-75-1

pyrrolidine

n-pentyl methyl ketone
110-43-0

n-pentyl methyl ketone

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

3-[3-(pyrrolidine-1-ylidenium)oct-1-ene-1-yl]rifamycin SV-8-olate

3-[3-(pyrrolidine-1-ylidenium)oct-1-ene-1-yl]rifamycin SV-8-olate

Conditions
ConditionsYield
With acetic acid In methanol at 45 - 50℃; for 2h;91.5%
formaldehyd
50-00-0

formaldehyd

1-Adamantanamine
768-94-5

1-Adamantanamine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C49H62N2O12

C49H62N2O12

Conditions
ConditionsYield
In pyridine for 2.75h; Ambient temperature;90%
formaldehyd
50-00-0

formaldehyd

ethylamine
75-04-7

ethylamine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C41H52N2O12

C41H52N2O12

Conditions
ConditionsYield
In pyridine at 66℃; for 0.33h;90%
N-Methylen-1,1,3,3-tetramethylbutylamin
13987-63-8

N-Methylen-1,1,3,3-tetramethylbutylamin

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

A

3-(tert-octylimino)methyl rifamycin SV

3-(tert-octylimino)methyl rifamycin SV

B

C47H64N2O12

C47H64N2O12

Conditions
ConditionsYield
In pyridine at 40℃; for 2.3h;A n/a
B 88%
formaldehyd
50-00-0

formaldehyd

cyclohexylamine
108-91-8

cyclohexylamine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C45H58N2O12

C45H58N2O12

Conditions
ConditionsYield
In pyridine at 42℃; for 3h;85%
formaldehyd
50-00-0

formaldehyd

tert-Octylamine
107-45-9

tert-Octylamine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C47H64N2O12

C47H64N2O12

Conditions
ConditionsYield
In pyridine at 43℃; for 4.5h;83%
pyrrolidine
123-75-1

pyrrolidine

1-(2,5-dimethylphenyl)-1-ethanone
2142-73-6

1-(2,5-dimethylphenyl)-1-ethanone

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

3-[3-(2,5-dimethylphenyl)-3-(pyrrolidine-1-ylidenium)prop-1-ene-1-yl]rifamycine-SV-8-olate

3-[3-(2,5-dimethylphenyl)-3-(pyrrolidine-1-ylidenium)prop-1-ene-1-yl]rifamycine-SV-8-olate

Conditions
ConditionsYield
With acetic acid In methanol at 45 - 50℃; for 1.25h;79.3%
pyrrolidine
123-75-1

pyrrolidine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

3-Methylacetophenone
585-74-0

3-Methylacetophenone

3-[3-(3-methylphenyl)-3-(pyrrolidine-1-ylidenium)prop-1-ene-1-yl]rifamycine-SV-8-olate

3-[3-(3-methylphenyl)-3-(pyrrolidine-1-ylidenium)prop-1-ene-1-yl]rifamycine-SV-8-olate

Conditions
ConditionsYield
With acetic acid In methanol at 45 - 50℃; for 1h;78.3%
formaldehyd
50-00-0

formaldehyd

2-Amino-2-methyl-1-propanol
124-68-5

2-Amino-2-methyl-1-propanol

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C43H56N2O13

C43H56N2O13

Conditions
ConditionsYield
In pyridine at 45℃; for 3h;78%
pyrrolidine
123-75-1

pyrrolidine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

2,4-dimethylacetophenone.
89-74-7

2,4-dimethylacetophenone.

3-[3-(2,4-dimethylphenyl)-3-(pyrrolidine-1-ylidenium)prop-1-ene-1-yl]rifamycine-SV-8-olate

3-[3-(2,4-dimethylphenyl)-3-(pyrrolidine-1-ylidenium)prop-1-ene-1-yl]rifamycine-SV-8-olate

Conditions
ConditionsYield
With acetic acid In methanol at 45 - 50℃; for 1.5h;74.9%
1-ethanesulfonylpiperazine
62937-96-6

1-ethanesulfonylpiperazine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C44H61N3O14S

C44H61N3O14S

Conditions
ConditionsYield
Stage #1: 3-formylrifamycin SV With hydrogenchloride In ethanol; dichloromethane at 20℃;
Stage #2: 1-ethanesulfonylpiperazine In methanol at 40℃; for 0.5h;
Stage #3: With sodium cyanoborohydride In methanol; ethanol; dichloromethane at 20℃; for 1h;
73%
pyrrolidine
123-75-1

pyrrolidine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

2-Methylacetophenone
577-16-2, 122382-54-1

2-Methylacetophenone

3-[3-(2-methylphenyl)-3-(pyrrolidine-1-ylidenium)prop-1-ene-1-yl]rifamycine-SV-8-olate

3-[3-(2-methylphenyl)-3-(pyrrolidine-1-ylidenium)prop-1-ene-1-yl]rifamycine-SV-8-olate

Conditions
ConditionsYield
With acetic acid In methanol at 45 - 50℃; for 0.75h;72.7%
4-amino-1-methanesulfonylpiperidine
402927-97-3

4-amino-1-methanesulfonylpiperidine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C44H61N3O14S

C44H61N3O14S

Conditions
ConditionsYield
Stage #1: 3-formylrifamycin SV With hydrogenchloride In ethanol; dichloromethane at 20℃;
Stage #2: 4-amino-1-methanesulfonylpiperidine In methanol at 40℃; for 0.5h;
Stage #3: With sodium cyanoborohydride In methanol; ethanol; dichloromethane at 20℃; for 1h;
72%
(S)-8-(3-aminomethyl-pyrrolidin-1-yl)-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid
874218-51-6

(S)-8-(3-aminomethyl-pyrrolidin-1-yl)-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

(S)-3-({[1-(3-carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-ylmethyl]-amino}-methyl)-rifamycin S

(S)-3-({[1-(3-carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-ylmethyl]-amino}-methyl)-rifamycin S

Conditions
ConditionsYield
Stage #1: (S)-8-(3-aminomethyl-pyrrolidin-1-yl)-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid; 3-formylrifamycin SV With sodium acetate In methanol; acetic acid at 20℃; for 2h;
Stage #2: With sodium cyanoborohydride In methanol; acetic acid at 20℃; for 3h;
71%
1-(2,4,6-trimethylbenzyl)-piperazine
41717-26-4

1-(2,4,6-trimethylbenzyl)-piperazine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C52H69N3O12

C52H69N3O12

Conditions
ConditionsYield
Stage #1: 3-formylrifamycin SV With hydrogenchloride In ethanol; dichloromethane at 20℃;
Stage #2: 1-(2,4,6-trimethylbenzyl)-piperazine In methanol at 40℃; for 0.5h;
Stage #3: With sodium cyanoborohydride In methanol; ethanol; dichloromethane at 20℃; for 1h;
71%
formaldehyd
50-00-0

formaldehyd

rac-2-aminooctane
44855-57-4, 693-16-3

rac-2-aminooctane

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C47H64N2O12

C47H64N2O12

Conditions
ConditionsYield
In pyridine for 5h; Ambient temperature;70%
3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

(R/S)-3-{[1-(3-carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-yl]-hydrazinomethyl}-rifamycin SV

(R/S)-3-{[1-(3-carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-yl]-hydrazinomethyl}-rifamycin SV

Conditions
ConditionsYield
Stage #1: (R/S)-1-cyclopropyl-7-fluoro-8-(3-hydrazino-pyrrolidin-1-yl)-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid (trifluoroacetate salt) With sodium acetate In methanol at 0℃; for 0.0833333h;
Stage #2: 3-formylrifamycin SV In methanol at 0℃; for 1h;
70%
3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

1-amino-2-propene
107-11-9

1-amino-2-propene

C41H54N2O12
1332223-29-6

C41H54N2O12

Conditions
ConditionsYield
Stage #1: 3-formylrifamycin SV; 1-amino-2-propene With hydrogenchloride; water In ethanol; dichloromethane at 45℃; for 0.5h;
Stage #2: With sodium cyanoborohydride In ethanol; dichloromethane at 20℃; for 0.166667h;
70%
formaldehyd
50-00-0

formaldehyd

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

tert-butylamine
75-64-9

tert-butylamine

(12S,3E,5S,13E,15Z)-7t-acetoxy-19-tert-butyl-15,9c,11t-trihydroxy-5r-methoxy-12,4,6t,8c,10c,12t,16-heptamethyl-19,10-dihydro-18H-2-oxa-1(2,7)-furo[2',3':5,6]benzo[1,2-g]quinazolina-cycloheptadecaphane-3,13,15-triene-11,6,11,17-tetraone

(12S,3E,5S,13E,15Z)-7t-acetoxy-19-tert-butyl-15,9c,11t-trihydroxy-5r-methoxy-12,4,6t,8c,10c,12t,16-heptamethyl-19,10-dihydro-18H-2-oxa-1(2,7)-furo[2',3':5,6]benzo[1,2-g]quinazolina-cycloheptadecaphane-3,13,15-triene-11,6,11,17-tetraone

Conditions
ConditionsYield
In pyridine at 42℃; for 3h;69%
3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

1-amino-3-(dimethylamino)propane
109-55-7

1-amino-3-(dimethylamino)propane

C43H61N3O12

C43H61N3O12

Conditions
ConditionsYield
Stage #1: 3-formylrifamycin SV; 1-amino-3-(dimethylamino)propane With hydrogenchloride; ethanol In dichloromethane at 45℃; for 0.5h;
Stage #2: With sodium cyanoborohydride at 20℃;
69%
1-Adamantanamine
768-94-5

1-Adamantanamine

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

C48H64N2O12

C48H64N2O12

Conditions
ConditionsYield
Stage #1: 3-formylrifamycin SV With hydrogenchloride In ethanol; dichloromethane at 20℃;
Stage #2: 1-Adamantanamine In methanol at 40℃; for 0.5h;
Stage #3: With sodium cyanoborohydride In methanol; ethanol; dichloromethane at 20℃; for 1h;
69%
3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

1-(4-fluorophenyl)methyl-piperazine
27469-60-9

1-(4-fluorophenyl)methyl-piperazine

C55H65F2N3O12

C55H65F2N3O12

Conditions
ConditionsYield
Stage #1: 3-formylrifamycin SV With hydrogenchloride In ethanol; dichloromethane at 20℃;
Stage #2: 1-(4-fluorophenyl)methyl-piperazine In methanol at 40℃; for 0.5h;
Stage #3: With sodium cyanoborohydride In methanol; ethanol; dichloromethane at 20℃; for 1h;
69%
formaldehyd
50-00-0

formaldehyd

3-formylrifamycin SV
13292-22-3

3-formylrifamycin SV

methylamine
74-89-5

methylamine

C40H50N2O12

C40H50N2O12

Conditions
ConditionsYield
In pyridine at 42℃; for 3.5h;68%

Rifamycin, 3-formyl- Specification

The Rifamycin, 3-formyl-, with CAS registry number 13292-22-3, belongs to the following product categories: (1)Various Metabolites and Impurities; (2)Intermediates & Fine Chemicals; (3)Metabolites & Impurities; (4)Pharmaceuticals. This chemical is a kind of black-red solid. Its classification code is Drug / Therapeutic Agent. And the chemical formula of this chemical is C38H47NO13. What's more, its EINECS is 236-311-5.

Physical properties of Rifamycin, 3-formyl-: (1)ACD/LogP: 2.85; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): 1.96; (4)ACD/LogD (pH 7.4): 0.24; (5)#H bond acceptors: 14; (6)#H bond donors: 6; (7)#Freely Rotating Bonds: 9; (8)Polar Surface Area: 218.38 Å2; (9)Index of Refraction: 1.633; (10)Molar Refractivity: 188.15 cm3; (11)Molar Volume: 526.5 cm3; (12)Polarizability: 74.58×10-24cm3; (13)Surface Tension: 68.8 dyne/cm; (14)Density: 1.37 g/cm3; (15)Flash Point: 508.3 °C; (16)Enthalpy of Vaporization: 139.67 kJ/mol; (17)Boiling Point: 916.9 °C at 760 mmHg; (18)Vapour Pressure: 0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: CC(=O)OC1C(C)C(O)C(C)C(O)C(C)\C=C\C=C(\C)C(=O)Nc4c(C=O)c(O)c3c2C(=O)C(C)(O/C=C/C(OC)C1C)Oc2c(C)c(O)c3c4O
(2)InChI: InChI=1/C38H47NO13/c1-16-11-10-12-17(2)37(48)39-28-23(15-40)32(45)25-26(33(28)46)31(44)21(6)35-27(25)36(47)38(8,52-35)50-14-13-24(49-9)18(3)34(51-22(7)41)20(5)30(43)19(4)29(16)42/h10-16,18-20,24,29-30,34,42-46H,1-9H3,(H,39,48)/b11-10+,14-13+,17-12-
(3)InChIKey: BBNQHOMJRFAQBN-AEZIOYLSBJ
(4)Std. InChI: InChI=1S/C38H47NO13/c1-16-11-10-12-17(2)37(48)39-28-23(15-40)32(45)25-26(33(28)46)31(44)21(6)35-27(25)36(47)38(8,52-35)50-14-13-24(49-9)18(3)34(51-22(7)41)20(5)30(43)19(4)29(16)42/h10-16,18-20,24,29-30,34,42-46H,1-9H3,(H,39,48)/b11-10+,14-13+,17-12-
(5)Std. InChIKey: BBNQHOMJRFAQBN-AEZIOYLSSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 416mg/kg (416mg/kg)   United States Patent Document. Vol. #4002754,
mouse LD50 intravenous 299mg/kg (299mg/kg)   "Structure-Activity Relationship among the Semisynthetic Antibiotics," Perlman, D., ed., New York, Academic Press, 1977Vol. -, Pg. 531, 1977.
mouse LD50 oral 907mg/kg (907mg/kg)   United States Patent Document. Vol. #4002754,

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View